2021 ISSWSH临床实践指南:应用系统性睾酮治疗女性机能减退的性欲障

2021-04-01 国外妇产科相关专家组 Climacteric.2021 Apr 1;1-18.

2021年4月,国际妇女性健康研究学会(ISSWSH)发布了应用系统性睾酮治疗女性机能减退的性欲障碍指南。本文主要针对睾酮治疗女性机能减退的性欲障碍提供实践指导,内容涉及患者识别,实验室检测,用药以及

中文标题:

2021 ISSWSH临床实践指南:应用系统性睾酮治疗女性机能减退的性欲障

英文标题:

International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women

发布日期:

2021-04-01

简要介绍:

2021年4月,国际妇女性健康研究学会(ISSWSH)发布了应用系统性睾酮治疗女性机能减退的性欲障碍指南。本文主要针对睾酮治疗女性机能减退的性欲障碍提供实践指导,内容涉及患者识别,实验室检测,用药以及用药后监测和治疗随访等。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 ISSWSH临床实践指南:应用系统性睾酮治疗女性机能减退的性欲障.pdf)] GetToolGuiderByIdResponse(projectId=1, id=d24641c00208319a, title=2021 ISSWSH临床实践指南:应用系统性睾酮治疗女性机能减退的性欲障, enTitle=International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women, guiderFrom=Climacteric.2021 Apr 1;1-18. , authorId=0, author=, summary=2021年4月,国际妇女性健康研究学会(ISSWSH)发布了应用系统性睾酮治疗女性机能减退的性欲障碍指南。本文主要针对睾酮治疗女性机能减退的性欲障碍提供实践指导,内容涉及患者识别,实验室检测,用药以及, cover=https://img.medsci.cn/2021420/1618929164862_2020535.jpg, journalId=0, articlesId=null, associationId=1214, associationName=国外妇产科相关专家组, associationIntro=国外妇产科相关专家组, copyright=0, guiderPublishedTime=Thu Apr 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年4月,国际妇女性健康研究学会(ISSWSH)发布了应用系统性睾酮治疗女性机能减退的性欲障碍指南。本文主要针对睾酮治疗女性机能减退的性欲障碍提供实践指导,内容涉及患者识别,实验室检测,用药以及用药后监测和治疗随访等。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=2036, tagName=睾酮), TagDto(tagId=111606, tagName=女性机能减退)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=14942, guiderKeyword=睾酮治疗, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=20711, appHits=90, showAppHits=0, pcHits=571, showPcHits=20621, likes=1, shares=15, comments=10, approvalStatus=1, publishedTime=Tue Apr 20 23:14:38 CST 2021, publishedTimeString=2021-04-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Apr 20 22:32:53 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 10:47:50 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ISSWSH临床实践指南:应用系统性睾酮治疗女性机能减退的性欲障.pdf)])
2021 ISSWSH临床实践指南:应用系统性睾酮治疗女性机能减退的性欲障.pdf
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1080670, encodeId=a91910806e04d, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 10:26:37 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975629, encodeId=92449e562905, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/265e74a2d3e34130b7b14ef31acfdeb1/d4f363235d244ac289e7c55d532de3bc.jpg, createdBy=13194884580, createdName=112549264, createdTime=Mon Jun 21 23:53:33 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966321, encodeId=eadb966321b9, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon May 17 18:04:48 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965585, encodeId=1b0196558526, content=好指南!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri May 14 16:02:31 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964635, encodeId=cff496463519, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue May 11 16:48:09 CST 2021, time=2021-05-11, status=1, ipAttribution=)]
    2021-12-16 龙珠

    学习好资料

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1080670, encodeId=a91910806e04d, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 10:26:37 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975629, encodeId=92449e562905, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/265e74a2d3e34130b7b14ef31acfdeb1/d4f363235d244ac289e7c55d532de3bc.jpg, createdBy=13194884580, createdName=112549264, createdTime=Mon Jun 21 23:53:33 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966321, encodeId=eadb966321b9, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon May 17 18:04:48 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965585, encodeId=1b0196558526, content=好指南!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri May 14 16:02:31 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964635, encodeId=cff496463519, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue May 11 16:48:09 CST 2021, time=2021-05-11, status=1, ipAttribution=)]
    2021-06-21 112549264

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1080670, encodeId=a91910806e04d, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 10:26:37 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975629, encodeId=92449e562905, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/265e74a2d3e34130b7b14ef31acfdeb1/d4f363235d244ac289e7c55d532de3bc.jpg, createdBy=13194884580, createdName=112549264, createdTime=Mon Jun 21 23:53:33 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966321, encodeId=eadb966321b9, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon May 17 18:04:48 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965585, encodeId=1b0196558526, content=好指南!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri May 14 16:02:31 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964635, encodeId=cff496463519, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue May 11 16:48:09 CST 2021, time=2021-05-11, status=1, ipAttribution=)]
    2021-05-17 jyzxjiangqin

    好文章!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1080670, encodeId=a91910806e04d, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 10:26:37 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975629, encodeId=92449e562905, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/265e74a2d3e34130b7b14ef31acfdeb1/d4f363235d244ac289e7c55d532de3bc.jpg, createdBy=13194884580, createdName=112549264, createdTime=Mon Jun 21 23:53:33 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966321, encodeId=eadb966321b9, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon May 17 18:04:48 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965585, encodeId=1b0196558526, content=好指南!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri May 14 16:02:31 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964635, encodeId=cff496463519, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue May 11 16:48:09 CST 2021, time=2021-05-11, status=1, ipAttribution=)]
    2021-05-14 jyzxjiangqin

    好指南!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1080670, encodeId=a91910806e04d, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 10:26:37 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975629, encodeId=92449e562905, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/265e74a2d3e34130b7b14ef31acfdeb1/d4f363235d244ac289e7c55d532de3bc.jpg, createdBy=13194884580, createdName=112549264, createdTime=Mon Jun 21 23:53:33 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966321, encodeId=eadb966321b9, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon May 17 18:04:48 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965585, encodeId=1b0196558526, content=好指南!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri May 14 16:02:31 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964635, encodeId=cff496463519, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue May 11 16:48:09 CST 2021, time=2021-05-11, status=1, ipAttribution=)]
    2021-05-11 jyzxjiangqin

    好文章!

    0

拓展阅读

2016 ESA立场声明:男性性功能减退症的评估和睾酮治疗的适应症

澳大利亚内分泌学会(ESA,Endocrine Society of Australia) · 2016-08-15

2018 TES临床实践指南:睾酮治疗男性性腺功能减退

美国内分泌学会(TES,The Endocrine Society) · 2018-03-17

2020 ACP临床指南:成年男性年龄相关性低睾酮水平的睾酮治疗

美国医师协会(ACP,American College of Physicians) · 2020-01-07